Stempeutics’ allogeneic cell therapy gets DCGI approval, Cipla to market and distribute… EP News Bureau Aug 20, 2020 Indicated for the treatment of CLI due to Buerger’s Disease and Atherosclerotic Peripheral Arterial Disease, it is the first…
DCGI gives limited approval to market Stempeutics’ allogeneic cell therapy Usha Sharma May 30, 2016 Stempeucel is used in the treatment of Buerger’s disease
